Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjogren's syndrome

Journal of Autoimmunity

Volumn 13, Issue 1, 1999, Pages 155-162

  Kolkowski, Edgardo C ^a   Reth, Peter ^a   Pelusa, Fabián ^b   Bosch, Josep ^a   Pujol Borrell, Ricardo ^a   Coll, Joaquín ^a   Jaraquemada, Dolores ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Univ Autónoma de Barcelona ^*

Author keywords

Autoimmunity; Cytokines; Perforin; Sjogren's syndrome; Th1

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; PERFORIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; BIOPSY; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION FUNCTION; CYTOKINE RELEASE; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; MALE; MINOR SALIVA GLAND; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME;

EID: 0032794141     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0289     Document Type: Conference Paper

References (46)

1. Talal N, Moutsopoulos H.M., Kassan S.S. Sjögren's syndrome: clinical and immunological aspects. 1987;Springer-Verlag, Berlin. p. 193-199.
2. Youinou P., Moutsopoulos H.M., Penec Y.L. Clinical features of Sjögren's syndrome. Curr. Opin. Rheumatol. 2:1990;287-293.
3. Isenberg D.A., Rowe D., Tookman A., Hopp A., Griffiths M., Paice F., Stewart J., Beverley P.C. An immunohistological study of secondary Sjögren's syndrome. Ann. Rheum. Dis. 43:1984;470-476.
4. Moutsopoulos H.M., Hooks J.J., Chan C.C., Dalavanga Y.A., Skopouli F.N., Detricket B. HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome. Ann. Rheum. Dis. 45:1986;677-683.
5. Coll J., Tomás S., Corominas J.M. Autoimmune sialadenitis: a form of onset of Sjögren's syndrome? Ann. Med. Interne. 146:1995;229-232.
6. Tomás S., Coll J., Reth P., Corominas J.M. Immunohistoquimical study of inflamatory infiltrates in minor salivary glands of patients with Sjögren's syndrome and other autoimmune disease. Med. Clin. 111:1998;681-686.
7. Kishimoto T., Taga T., Akura S. Cytokine signal transduction. Cell. 76:1994;253-262.
8. Carter L.L., Dutton R.W. Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets. Curr. Op. Immunol. 3:1996;336-342.
9. +T cells in the pathogenesis of organ-specific autoimmune disease. Immunol. Today. 16:1995;34-38.
10. Umetsu D.T., Jabara H.H., DeKruyff R.H., Abbas A.K., Abrams J.S., Geha R.S. Functional heterogeneity among human inducer T-cell clones. J. Immunol. 140:1988;4211-4216.
11. +and CD8- T-cell clones. J. Immunol. 141:1988;849-855.
12. Romagnani S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 12:1994;227-257.
13. Williams N.S., Enelhard V.H. Identification of a population of CD4 CTL that utilizes a perforin-rather than FasL-dependent cytotoxic mechanism. J. Immunol. 156:1996;153-159.
14. Lichtenheld M.G., Olsen K.J., Lu P., Lowrey D.M., Hameed A., Hengartner H., Podack E.R. Structure and function of human perforin. Nature. 335:1988;448-451.
15. Podack E.R., Hengartner H., Lichtenheld M.G. A central role of perforin in cytolysis. Ann. Rev. Immunol. 9:1991;129-157.
16. +T cells. J. Immunol. 148:1992;3354-3360.
17. Polihronis M., Tapinos N.I., Theocharis S.E., Economou A., Kittas C., Moutsopoulos H.M. Modes of epithelial cell death and repair in Sjögren's syndrome. Clin. Exp. Immunol. 114:1998;485-490.
18. Fox R.I., Kang H.I., Ando D., Abrams J., Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J. Immunol. 152:1994;5532-5539.
19. Boumba D., Skopouli F.N., Moutsopoulos H.M. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br. J. Rheumatol. 34:1995;326-333.
20. Ohyama Y., Nakamura S., Matsuzaki G., Shinohara M., Hiroki A., Fujimura T., Yamada A., Itoh K., Nomoto K. Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 39:1996;1376-1384.
21. Vitali, C. Bombardieri, S. Moutsopoulos, H.M. European Community Study Group on Diagnostic Criteria for Sjögren's Syndrome 1996. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study, Ann. Rheum. Dis. 55, 116, 121.
22. Vitali C., Moutsopoulos H.M., Bombardieri S. European Community Study Group on Diagnostic Criteria for Sjögren's Syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann. Rheum. Dis. 53:1994;637-647.
23. Chisholm D.M., Mason D.K. Labial salivary gland biopsy in Sjögren's disease. J. Clin. Pathol. 21:1968;656-660.
24. Daniels T.E. Labial salivary gland biopsy in Sjögren's syndrome. Arthritis Rheum. 27:1984;147-156.
25. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
26. Sospedra M., Ferrer-Francesch X., Domínguez O., Juan M., Foz-Sala M., Pujol-Borrell R. Transcription of a broad range of self antigens in human thymus suggests a role for central mechanisms in tolerance towards peripheral antigens. J. Immunol. 161:1998;5918-5929.
27. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-91.
28. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T., Hartley S.B., Menon S., Kastelein R., Bazan F., O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for interferon γ production and activates IRAK and NF κ B. Immunity. 7:1997;571-581.
29. Coll J., Tomás S., Vilella R., Corominas J. Interleukin-2 receptor expression in salivary glands of patients with primary Sjögren's syndrome. J. Rheumatol. 22:1995;1488-1491.
30. Roura-Mir C., Catálfamo M., Sospedra M., Alcalde L., Pujol-Borrell R., Jaraquemada D. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Eur. J. Immunol. 27:1997;3290-3302.
31. De Waal Malefyt R., Abrams J., Bennett B., Figdor C., De Vries J. Interleukin 10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
32. Burdin N., Péronne C., Banchereau J., Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J. Exp. Med. 177:1993;295-304.
33. Enk A.H., Katz S.I. Identification and induction of keratinocyte-derived IL-10. J. Immunol. 149:1992;92-95.
34. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151:1993;4562-4573.
35. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Morel Fourrier B., Galanaud P., Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. Arthritis Rheum. 37:1994;1647-1655.
36. Van Snick J. Interleukin-6: an overview. Ann. Rev. Immunol. 8:1990;253-278.
37. Beutler B., Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature. 320:1986;584-588.
38. Wahl S.M., McCartney-Francis N., Mergenhagen S.T. Inflammatory and immunoregulatory roles of TGF-β Immunol. Today. 23:1989;258-261.
39. Ogawa N., Dang H., Lazaridis K., Aufdemore T.B., Talal N. Analysis of transforming growth factor beta and other cytokines in autoimmune exocrinopathy (Sjögren's syndrome). J. Inter. Cyt. Res. 15:1995;759-767.
40. Skopouli F., Moutsopoulos H.M. Cytokines in Sjögren's syndrome. Ann. Med. Intern. 146:1995;219-222.
41. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.I., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
42. Wu Z., Podack E.R., McKenzie J.M., Olsen K.J., Zakarija M. Perforin expression by thyroid-infiltrating T cells in autoimmune thyroid disease. Clin. Exp. Immunol. 98:1994;470-477.
43. Reth P., Kolkowski E., Coll J., Pelusa F., Goday A., Bosch J., Pujol-Borrell R., Jaraquemada D. Cytokine mRNA expression in minor salivary gland biopsies of primary Sjögren's syndrome patients with and without autoimmune thyroid disease. Clin. Exp. Rheum. 16:1998;206.
44. Moutsopoulos H.M. New insights into the physiopathology of primary Sjögren's syndrome. Ann. Med. Intern. 141:1990;53-56.
45. Kassan S.S., Thomas T.L., Moutsopoulos H.M., Hoover R., Kimberly R.P., Budman D.R., Costa J., Decker J.L., Chused T.M. Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89:1978;888-892.
46. De Vita S., Dolcetti R., Ferraccioli G., Pivetta B., De Re V., Gloghini A., D'Agosto A., Bartoli E., Carbone A., Boiocchi M. Local cytokine expression in the progression toward B cell malignancy in Sjögren's syndrome. I. Rheumatol. 22:1995;1674-1680.